APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,017,313 | +29.0% | 76,066 | +1.1% | 0.76% | +19.5% |
| Q4 2022 | $3,889,471 | +2.8% | 75,217 | +35.8% | 0.64% | -2.0% |
| Q3 2022 | $3,783,000 | -35.8% | 55,384 | -57.5% | 0.65% | -35.3% |
| Q2 2022 | $5,894,000 | -10.9% | 130,340 | +0.1% | 1.00% | +19.1% |
| Q1 2022 | $6,616,000 | -36.9% | 130,208 | -41.3% | 0.84% | -23.7% |
| Q4 2021 | $10,491,000 | +104.0% | 221,901 | +42.2% | 1.11% | +107.5% |
| Q3 2021 | $5,143,000 | – | 156,031 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |